Drug research

AP01

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Pirfenidone Solution

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)NCT06951217	AVLN	Phase 2	Recruiting	2031-12-31Estimated
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisNCT06329401	AVLN	Phase 2	Active not recruiting	2027-06Estimated

AVLNRecruitingPrimary completion: 2031-12-31 · Estimated

Trial details

AVLNActive not recruitingPrimary completion: 2027-06 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.